Source: NOVARTIS - “In China, Novartis works with about 100,000 farmers who cultivate Artemisia Annua, a crucial plant in the production of our antimalarial treatment.”
Papers reviewed:
2023 Oct.11 - Baggieri et al - Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2
2023 Oct.30 - Agrawal et al - RETRACTED: Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?
2022 Feb - Farmanpour-Kalalagh et al - Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
2022 Jan - Iftekhar Ahmad et al - Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible Mechanisms
2021 Sep - Fuzimoto - An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
